Abstract:NLRC5, the largest member of the nucleotide-binding and oligomerization domain (NOD)-like receptor (NLR) family, has been reported to participate in the regulation of immune function and is associated with chronic inflammatory diseases. However, the biological function of NLRC5 in hepatocellular carcinoma (HCC) has not been fully demonstrated. The aim of this study is to evaluate NLRC5 expression in the tumor tissues of HCC patients undergoing surgical treatment, assess its prognostic value, and explore its relationship with critical immune-related molecules within the tumor microenvironment. A total of 100 patients with hepatitis B virus-associated HCC receiving surgical treatment were enrolled in the study. Immunohistochemical results were obtained by scoring the intensity of cellular staining and the percentage of positive cells in the tissue sections. The association between NLRC5 expression levels and the main clinicopathological factors was analyzed by Chi-square test method. The prognostic values were analyzed by COX regression model and the Kaplan-Meier survival curve. Receiver operating characteristic (ROC) curve analysis was performed to assess the predictive performance of NLRC5 in postoperative patients with HCC. IHC showed that high expression of NLRC5 was observed in 67% of HCC tissue samples. Chi-square test showed that NLRC5 was a risk factor associated with tumor number, satellite nodule, and envelope invasion. Kaplan-Meier survival curves and COX survival analysis showed that high expression of NLRC5 was significantly associated with decreased overall survival (OS) in HCC patients (HR = 1.79, 95% CI 1.03-3.12, p = .041). However, univariate logistic regression analysis revealed that NLRC5 showed positive relationship with GZMB and CD8α suggesting its role in immune escape of HCC. ROC curve analysis showed that the combination of tumor number, envelope invasion, and NLRC5 expression (area under the curve = 0.824, sensitivity = 77.30%, specificity = 82.4%) can more accurately evaluate the prognosis of HCC patients compared to the combination of only tumor number and envelope invasion (area under the curve = 0.690, sensitivity = 43.9%, specificity = 94.1%).NLRC5 plays a crucial role in progression of HCC and can be considered as a potential prognostic and predictive biomarker. Targeting NLRC5 may provide an attractive therapeutic approach for HCC.

Expression and Prognostic Value of Nuclear RNA Export Factor 3 in Hepatocellular Carcinoma

Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma.

Preoperative Neutrophil-to-lymphocyte Ratio is an Independent Prognostic Predictor for AFP Negative Hepatocellular Carcinoma after Hepatectomy

High RNF40 Expression Indicates Poor Prognosis of Hepatocellular Carcinoma.

Correlation of nm23 and E-cadherin protein expression with recurrence and metastasis after liver transplantation for hepatocellular carcinoma

Expression and Prognostic Impact of NTF3 and TrkC in Hepatocellular Carcinoma.

Expression Levels of Lncrnas Are Prognostic for Hepatocellular Carcinoma Overall Survival.

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection

Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma

Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma

NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated with CCL5 and CXCL9 in HCC Patients

The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma

Expression and prognostic value of ING3 in human primary hepatocellular carcinoma.

The prognostic significance of neutrophil-to-lymphocyte ratio at different time points in patients with hepatocellular carcinoma receiving liver resection

Expression and clinical significance of NLRC5 in hepatocellular carcinoma

Correlation of APOBEC3 in Tumor Tissues with Clinico-Pathological Features and Survival from Hepatocellular Carcinoma after Curative Hepatectomy.

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection

LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma

Increased Expression of Vascular Endothelial Growth Factor-C and Nuclear Cxcr4 in Hepatocellular Carcinoma is Correlated with Lymph Node Metastasis and Poor Outcome

High Nuclear ABCG1 Expression is a Poor Predictor for Hepatocellular Carcinoma Patient Survival